Your browser doesn't support javascript.
loading
Unmet needs in relapsed/refractory mantle cell lymphoma after failure of covalent Bruton's tyrosine kinase inhibitors: An Italian scenario.
Pinto, Antonio; Ladetto, Marco; Martelli, Maurizio; Visco, Carlo; Zaja, Francesco; Guardalben, Emanuele; Zinzani, Pier Luigi.
Affiliation
  • Pinto A; Department of Hematology and Developmental Therapeutics, Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS, Naples, Italy.
  • Ladetto M; Hematology, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
  • Martelli M; Department of Translational and Precision Medicine, Sapienza University Rome, Rome, Italy.
  • Visco C; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Zaja F; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  • Guardalben E; Eli Lilly Italy S.p.A., Medical Affairs, Sesto Fiorentino, Italy.
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Hematol Oncol ; 42(1): e3246, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38287533
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell / Antineoplastic Agents Limits: Adult / Humans Country/Region as subject: Europa Language: En Journal: Hematol Oncol Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell / Antineoplastic Agents Limits: Adult / Humans Country/Region as subject: Europa Language: En Journal: Hematol Oncol Year: 2024 Document type: Article Affiliation country: Country of publication: